Test Bank for PMHNP Boards 2024 Questions and Answers
Already Passed
What vis vtrue vof vinterprofessionality? v✔✔All vhealth vprofessionals vhave vindividual vprofessional vcompetencies
What vis vthe vsignificance vof van vexperimental vp-value vof v0.05 v✔✔There vis va v5% vchance vof va vsimilar vresult voccurring vby vchance valone
What vpercentage vof vchildren vwith voppositional vdefiance vdisorder vwill vdevelop vconduct vdisorder?
✔✔30%
In vthe vDSM-5, vselective vmutism vis vnow vconsidered vwhat vtype vof vdisorder? v✔✔anxiety vdisorder
Symptoms vof vselective vmutism vmust vpersist vfor vat vleast v✔✔1 vmonth
Common vcompetencies v✔✔overlap vmore vthan vone vhealth vcare vprofessional, valthough vnot
vnecessarily vall vhealth vcare vprofessionals, vand vare vcompetencies vexpected vof vall vhealth
vcare vprofessionals
Complementary vcompetencies v✔✔enhance vthe vqualities vof vother vprofessions vin vprovision vof vcare
Collaborative vcompetencies v✔✔those vthat veach vindividual vprofession vmust vpossess vto vwork vwith vothers, vincluding vthose vwho vpractice vwithin vdifferent vspecialties vwithin va vprofession.
Interpersonal vcollaboration vis v centered v✔✔patient
Cognitive vtherapy vis vrecommended vfor vpatients vthat vhave v✔✔negative vcognitive vdistortions virrational vbeliefs faulty vconceptions
Humanistic vTherapy vfocuses von vassisting vpatients vwith v✔✔self-actualization vand vself-
directed vgrowth
Behavioral vTherapy vfocuses von v✔✔changing vmaladaptive vbehaviors vthrough vthe vuse vof vbehavioral vmodification vtechniques
Existential vtherapy vis vfor v✔✔reflection von vlife vconfronting vself
120 vwho vgot vdiarrhea vate vlettuce. v80 vwith vdiarrhea vdid vnot veat vlettuce. v40 vwithout
vdiarrhea vate vlettuce. v160 vwithout vdiarrhea vate vlettuce. vWhat vis vthe vodds vratio vof veating
vlettuce vand vdeveloping vdiarrhea? v✔✔6 v((120X160)/(80x40))
The vNew vFreedom vCommission von vMental vHealth v(NFCMH) vreleased va vreport vthat vsuggested
✔✔implementation va vnational vcampaign vto vreduce vthe vstigma vof vseeking
vcare vFocusing von vpromoting vrecovery vand vbuilding vresilience
The vefficacy vof vmental vhealth vtreatments vwas vfound vto vbe vwell vdocumented vin v✔✔influential vreport vissued vby vUS vSurgeon vGeneral vin v1999
State vof vhigh vnegative vemotion vand vpessimism v✔✔neuroticism
Commonly vknown vas van voptimistic voutlook von vlife vThey vare vare voutgoing, vlike vsocial
vinteraction, vrespond vto vexternal vrewards, vhave vmore vactive vdopamine vnetworks, vand vare
vresponsive vto vpositive vreinforcement. v✔✔Extraversion v(high vlevels vprotect vfrom
vpsychiatric villness)
Introverts vare vmore vlikely vto vbe v vmotivated vand vmore vlikely vto vrespond vto v vreinforcement v✔✔internally negative v(more vlikely vto vinteract vwith vinternal vmotivation/self-image)
Interpersonal vtrait vof vcooperation, veasy vgoing vnature. vTend vto vhave vsmooth vrelationships
voften vat vthe vexpense vof vself-assertion v✔✔Agreeableness
Associated vwith vself-control vand va vfocused, vorganized vapproach vto vlife. vAre vachievement-
oriented vgoal vsetters vwho vcan vdelay vimmediate vgratification vto vobtain vtheir vlong vterm
vdesired voutcome. vThey vare vconsidered vresponsible, vreliable, vand vdependable.
v✔✔conscientiousness
In vbehavioral vcouples vtherapy, vthe vinitial vsessions vare vspent vdoing va vfunctional vanalysis vof
vbehavior v(FAB). vWhat vis vtrue vabout vFAB? v✔✔FAB vis vconcerned vonly vwith vobservable
vstimuli vconnected vto voperant vbehavior
FAB vis vbased von voperant vconditioning v(identifying vantecedent vstimuli, voperant vbehaviors,
vand vconsequent vstimuli)
The vgoal vof vFAB vis vmodifying vwillful voperant vbehavior
Gestalt vtheory vdeals vwith v , vnot v v✔✔perceptual vpsychology vbehavior
Medication vthat vcan vdelay vejaculation vin vpatients vwith vpremature vejaculation v✔✔Paroxetine v(and vother vSSRIs)
(others vinclude:
Topical vanesthetic vTramadol
Phosphodiesterase-5 vinhibitors)
First vline vtreatment vfor vlithium vinduced vdiabetes vinsipidus v✔✔Amiloride v(K vpotassium vdiuretic) vin vaddition vto vdc vlithium vwhen vpossible. Ways vto vreduce vpolyuria vassociated vwith vlithium vtoxicity v✔✔reduce vlithium vdose vto vminimum veffective vdose
take vonce vdaily vat vnight v(may vbe v5-30% vlower vthan vwhen vgiven vin vdivided vdoses vover vthe vday) vEncourage vadequate vfluid vintake
What vis vtrue vabout vECT vin vParkinson's vdisease v✔✔it's vmore vlikely vto vcause vtransient vdelirium v(worsened vdyskinesias vinduced vby vl-dopa)
Lithium veffects vwith vParkison's vdisease v✔✔may vworsen vtremor
nonselective vMAOIs vdecrease vthe vefficacy vof v and vincrease vthe vrisk vof va v v✔✔l- vdopa vproducts
hypertensive vcrisis
Selegiline vis vselective vfor v✔✔MAO-B
(after v10mg vthere vis van vincrease vin vrisk vof vserotonin vsyndrome vif vgiven vwith vother vmeds vthat vincrease vserotonin)
SSRI's vcan v Parkinsonism vtremor v✔✔worsen v(and vdecrease v'off vtime')
Process vdescribes vthe vmechanism vby vwhich vthe vhippocampus vstores vmemories v✔✔long-
term vpotentiation
loss vof vmemory vrelating vto va vparticular vcategory vof vinformation v(inability vto vrecall
vimportant vautobiographical vinformation, vusually vof va vtraumatic vor vstressful vnature, vthat vis
vinconsistent vwith vordinary vforgetting) v✔✔systematized vamnesia
Lack vof vmemories vfrom va vcircumscribed vperiod vof vtime, vusually vimmediately vfollowing va
vtraumatic vevent v✔✔localized vamnesia
Already Passed
What vis vtrue vof vinterprofessionality? v✔✔All vhealth vprofessionals vhave vindividual vprofessional vcompetencies
What vis vthe vsignificance vof van vexperimental vp-value vof v0.05 v✔✔There vis va v5% vchance vof va vsimilar vresult voccurring vby vchance valone
What vpercentage vof vchildren vwith voppositional vdefiance vdisorder vwill vdevelop vconduct vdisorder?
✔✔30%
In vthe vDSM-5, vselective vmutism vis vnow vconsidered vwhat vtype vof vdisorder? v✔✔anxiety vdisorder
Symptoms vof vselective vmutism vmust vpersist vfor vat vleast v✔✔1 vmonth
Common vcompetencies v✔✔overlap vmore vthan vone vhealth vcare vprofessional, valthough vnot
vnecessarily vall vhealth vcare vprofessionals, vand vare vcompetencies vexpected vof vall vhealth
vcare vprofessionals
Complementary vcompetencies v✔✔enhance vthe vqualities vof vother vprofessions vin vprovision vof vcare
Collaborative vcompetencies v✔✔those vthat veach vindividual vprofession vmust vpossess vto vwork vwith vothers, vincluding vthose vwho vpractice vwithin vdifferent vspecialties vwithin va vprofession.
Interpersonal vcollaboration vis v centered v✔✔patient
Cognitive vtherapy vis vrecommended vfor vpatients vthat vhave v✔✔negative vcognitive vdistortions virrational vbeliefs faulty vconceptions
Humanistic vTherapy vfocuses von vassisting vpatients vwith v✔✔self-actualization vand vself-
directed vgrowth
Behavioral vTherapy vfocuses von v✔✔changing vmaladaptive vbehaviors vthrough vthe vuse vof vbehavioral vmodification vtechniques
Existential vtherapy vis vfor v✔✔reflection von vlife vconfronting vself
120 vwho vgot vdiarrhea vate vlettuce. v80 vwith vdiarrhea vdid vnot veat vlettuce. v40 vwithout
vdiarrhea vate vlettuce. v160 vwithout vdiarrhea vate vlettuce. vWhat vis vthe vodds vratio vof veating
vlettuce vand vdeveloping vdiarrhea? v✔✔6 v((120X160)/(80x40))
The vNew vFreedom vCommission von vMental vHealth v(NFCMH) vreleased va vreport vthat vsuggested
✔✔implementation va vnational vcampaign vto vreduce vthe vstigma vof vseeking
vcare vFocusing von vpromoting vrecovery vand vbuilding vresilience
The vefficacy vof vmental vhealth vtreatments vwas vfound vto vbe vwell vdocumented vin v✔✔influential vreport vissued vby vUS vSurgeon vGeneral vin v1999
State vof vhigh vnegative vemotion vand vpessimism v✔✔neuroticism
Commonly vknown vas van voptimistic voutlook von vlife vThey vare vare voutgoing, vlike vsocial
vinteraction, vrespond vto vexternal vrewards, vhave vmore vactive vdopamine vnetworks, vand vare
vresponsive vto vpositive vreinforcement. v✔✔Extraversion v(high vlevels vprotect vfrom
vpsychiatric villness)
Introverts vare vmore vlikely vto vbe v vmotivated vand vmore vlikely vto vrespond vto v vreinforcement v✔✔internally negative v(more vlikely vto vinteract vwith vinternal vmotivation/self-image)
Interpersonal vtrait vof vcooperation, veasy vgoing vnature. vTend vto vhave vsmooth vrelationships
voften vat vthe vexpense vof vself-assertion v✔✔Agreeableness
Associated vwith vself-control vand va vfocused, vorganized vapproach vto vlife. vAre vachievement-
oriented vgoal vsetters vwho vcan vdelay vimmediate vgratification vto vobtain vtheir vlong vterm
vdesired voutcome. vThey vare vconsidered vresponsible, vreliable, vand vdependable.
v✔✔conscientiousness
In vbehavioral vcouples vtherapy, vthe vinitial vsessions vare vspent vdoing va vfunctional vanalysis vof
vbehavior v(FAB). vWhat vis vtrue vabout vFAB? v✔✔FAB vis vconcerned vonly vwith vobservable
vstimuli vconnected vto voperant vbehavior
FAB vis vbased von voperant vconditioning v(identifying vantecedent vstimuli, voperant vbehaviors,
vand vconsequent vstimuli)
The vgoal vof vFAB vis vmodifying vwillful voperant vbehavior
Gestalt vtheory vdeals vwith v , vnot v v✔✔perceptual vpsychology vbehavior
Medication vthat vcan vdelay vejaculation vin vpatients vwith vpremature vejaculation v✔✔Paroxetine v(and vother vSSRIs)
(others vinclude:
Topical vanesthetic vTramadol
Phosphodiesterase-5 vinhibitors)
First vline vtreatment vfor vlithium vinduced vdiabetes vinsipidus v✔✔Amiloride v(K vpotassium vdiuretic) vin vaddition vto vdc vlithium vwhen vpossible. Ways vto vreduce vpolyuria vassociated vwith vlithium vtoxicity v✔✔reduce vlithium vdose vto vminimum veffective vdose
take vonce vdaily vat vnight v(may vbe v5-30% vlower vthan vwhen vgiven vin vdivided vdoses vover vthe vday) vEncourage vadequate vfluid vintake
What vis vtrue vabout vECT vin vParkinson's vdisease v✔✔it's vmore vlikely vto vcause vtransient vdelirium v(worsened vdyskinesias vinduced vby vl-dopa)
Lithium veffects vwith vParkison's vdisease v✔✔may vworsen vtremor
nonselective vMAOIs vdecrease vthe vefficacy vof v and vincrease vthe vrisk vof va v v✔✔l- vdopa vproducts
hypertensive vcrisis
Selegiline vis vselective vfor v✔✔MAO-B
(after v10mg vthere vis van vincrease vin vrisk vof vserotonin vsyndrome vif vgiven vwith vother vmeds vthat vincrease vserotonin)
SSRI's vcan v Parkinsonism vtremor v✔✔worsen v(and vdecrease v'off vtime')
Process vdescribes vthe vmechanism vby vwhich vthe vhippocampus vstores vmemories v✔✔long-
term vpotentiation
loss vof vmemory vrelating vto va vparticular vcategory vof vinformation v(inability vto vrecall
vimportant vautobiographical vinformation, vusually vof va vtraumatic vor vstressful vnature, vthat vis
vinconsistent vwith vordinary vforgetting) v✔✔systematized vamnesia
Lack vof vmemories vfrom va vcircumscribed vperiod vof vtime, vusually vimmediately vfollowing va
vtraumatic vevent v✔✔localized vamnesia
